Penny stocks, defined as stocks trading under $5 per share, present traders and investors with opportunities for explosive returns. However, the penny stock territory also comes loaded with substantial risks. Analyst ratings can serve as an important data point to help uncover promising penny stocks worth watching.
Using Analyst Ratings to Find Penny Stock Opportunities
Analysts are experts who provide independent analysis and stock recommendations. Their ‘Buy’ ratings on penny stocks indicate the analyst sees strong upside potential. However, analysts can miss the mark in their assessments. While not the only criteria, integrating analyst ratings into your penny stock filtering process may help uncover hidden gems with solid fundamentals before they grab Wall Street’s attention.
Evaluating Risks and Rewards of Penny Stocks
It’s crucial to grasp that analyst ratings represent opinions, not guarantees a stock will perform. Penny stocks have inherent risks like liquidity shortages, large spreads, dilution, and volatility. Many are newer businesses in their early stages. Do thorough due diligence and never invest more than you can afford to lose.
Diversification is also key when buying penny stocks. Even those with positive analyst ratings can swing wildly. Spreading capital over multiple stocks rather than over-concentrating helps manage risk. Consider allocating only a portion of your portfolio to penny stock speculating.
Performing Due Diligence on Analyst-Rated Picks
While analyst ratings may help point to promising penny stocks to watch, they should not be the sole filtering criteria. Combining ratings with your own comprehensive research is key. Performing diligent due diligence involves scrutinizing financials, leadership, industry trends, and technical factors, and closely reviewing the stock’s upside potential versus downside risks. It’s also prudent to consider using wise position sizing, price targets, and stop losses when trading analyst-rated penny stocks.
Penny Stocks To Watch
With diligent research, analyst-rated penny stocks may provide a path to outsized returns on small investments. However, careful due diligence is required to avoid getting burned by the risks.
- Traeger Grills (NYSE: COOK)
- Outlook Therapeutics Inc. (NASDAQ: OTLK)
- Holley Inc. (NYSE: HLLY)
Traeger Grills (COOK)
Traeger Grills is a pioneering brand in outdoor cooking. It has made headway in wood pellet grill technology. Based in Salt Lake City, their grills offer versatile cooking options, from grilling to barbecuing. But it’s not the product portfolio cooking up excitement. Shares of COOK stock are heating up in the stock market this week in advance of Q3 earnings.
– 5 Most Active Penny Stocks Today, Time To Buy?
Traeger has announced the release of its Q3 2023 financial results on November 8, 2023, post-market close. A conference call hosted by management will follow at 4:30 p.m. Eastern Time, discussing the financial outcomes. The release of these financial results could influence Traeger’s stock price. Positive outcomes may bolster confidence, while unfavorable results might have the opposite effect. In the meantime, speculation is becoming a driving force.
What do analysts think? Telsey Advisory Group has an Outperform rating on the penny stock. The firm also has set a COOK stock forecast price of $6.50, up more than 123% from recent trading levels.
Outlook Therapeutics Inc. (OTLK)
Outlook Therapeutics, a biopharmaceutical company, strives for FDA approval for its ophthalmic formulation of bevacizumab to treat retinal diseases, particularly wet Age-Related Macular Degeneration (AMD).
The company updated on its Type A meetings with the FDA regarding the Complete Response Letter (CRL) for ONS-5010’s Biologics License Application (BLA). The FDA necessitated an additional clinical trial for approval, and a preliminary agreement on trial design was reached, targeting a BLA resubmission by end-2024, with potential approval around mid-2025, contingent on final agreement and successful trial completion.
“We are confident that we can meet the additional requirements that the FDA is requiring for approval of ONS-5010. The retina community of patients, physicians, and payers are all in need of an FDA-approved bevacizumab that meets ophthalmic standards for the treatment of wet AMD, and we remain focused on achieving this critical treatment option,” said Russell Trenary, President and CEO of Outlook Therapeutics.
This week HC Wainwright boosted its OTLK stock forecast price target on the company. The firm maintains a Buy rating and now has a target of $2, 365% higher than recent trading levels.
Holley Inc. (HLLY)
Holley is a leader in the automotive aftermarket industry. Over the last few weeks, the company has released several milestone updates. It unveiled a new market segment strategy at SEMA 2023, spotlighting a wide array of aftermarket solutions for different vehicle types.
At SEMA 2023, Holley showcased its Sniper 2 electronic fuel injection technology alongside other innovative aftermarket solutions, reflecting its expanded focus on various vehicle segments, including classic, late model, and electric vehicles. This new strategy aims to capture a broader market and meet diverse customer needs.
More recently, Holley and Detroit Speed & Engineering, have collaborated with celebrity Kevin Hart to restore a 1969 Pontiac GTO. This collaboration could bolster Holley’s brand recognition. The showcased expertise in car restoration and high-performance products might positively influence attention on the company.
– Penny Stocks To Buy Now? 4 To Watch Before Next Week
But what about analysts? The latest HLLY stock forecast price from Benchmark sits 181% higher than its latest trading levels at the end of the week. The first has a Buy rating and a $12 price target.
